SCHEMBL3427248

SCHEMBL3427248

[c]1ccc(CC[C@H]2CNCCO2)cn1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 12/20 0.39
SLC6A4 P31645 10/20 0.39
SLC6A3 Q01959 9/20 0.39
HTR2A P28223 4/20 0.39
HTR2B P41595 2/20 0.39
ADRB2 P07550 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA2C P18825 1/20 0.39
HRH1 P35367 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
HTR3A P46098 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1786507 1.00 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL1784565 0.78 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL3407447 0.78 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL9432019 0.77 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL78044 0.76 DRD4 (0.51) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL8924483 0.76 DRD4 (0.51) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL18689815 0.73 HRH1 (0.43) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL6978725 0.73 GFER (0.44) SLC6A2SLC6A4SLC6A3HTR2AHTR2B
SCHEMBL21254392 0.73 DRD4 (0.52) SLC6A2SLC6A4SLC6A3
SCHEMBL27658505 0.73 DRD2 (0.51) SLC6A2SLC6A4SLC6A3HTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2252293-A2 KINASE INHIBITORS AND METHODS OF USE Intellikine, Inc. (US) 2010-11-24 EP disclosed
WO-2009114870-A2 KINASE INHIBITORS AND METHODS OF USE INTELLIKINE, INC. (US) 2009-09-17 WO disclosed
WO-2009114874-A2 BENZOTHIAZOLE KINASE INHIBITORS AND METHODS OF USE INTELLIKINE, INC. (US) 2009-09-17 WO disclosed